Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets
A novel severe acute respiratory syndrome COVID-19 caused by coronavirus SARS-CoV-2 has been confirmed to infect more than 100 million people globally, with mortality reaching nearly 3 million as of March 2021.